NCT01832870View on ClinicalTrials.gov

Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

9

Participants

Timeline

Start Date

April 30, 2013

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions
Prostate CancerCastrate Resistant Prostate Cancer
Interventions
DRUG

sipuleucel-T

DRUG

ipilimumab

Trial Locations (1)

90292

Prostate Oncology Specialists, Inc., Marina del Rey

All Listed Sponsors
lead

Prostate Oncology Specialists, Inc.

OTHER

NCT01832870 - Sipuleucel-T and Ipilimumab for Advanced Prostate Cancer | Biotech Hunter | Biotech Hunter